(Total Views: 134)
Posted On: 09/04/2019 10:00:47 AM
Post# of 89577
$MREO News Article - Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting https://marketwirenews.com/news-releases/mere...60137.html
(0)
(0)
My Twitter: WhyteStocks
